Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ye Zhang
Institution:
Guilin Medical University
Observed institutions:
Guilin Medical University,
Yulin Normal University,
Guangxi Normal University,
State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources
ORCID:
0000-0003-0290-6773
Observed ORCID:
0000-0003-0290-6773
OpenAlex ID:
A5091375153
Recent advances in ruthenium (III) complex-loaded nanomaterial for enhanced cancer therapy efficacy
2025
·
Xuemei Zhong
, Ye Zhang
, et al.
·
Drug Development and Industrial Pharmacy
·
10
A Cyclometalated Iridium(III) Complex Exerts High Anticancer Efficacy via Fatty Acid Beta-Oxidation Inhibition and Sphingolipid Metabolism Reprogramming
2024
·
Cuiyan Lin
, Huiling Wang
, et al.
·
Journal of Medicinal Chemistry
·
7
Boosting Energy Deprivation via Synchronous Interventions of Oxidative Phosphorylation and Glycolysis for Cancer Therapy with 1,8-Naphthyridine-Piperazine-Dithiocarbamate Ruthenium(II) Polypyridyl Complexes
2025
·
Huiling Wang
, Lei Chen
, et al.
·
Journal of Medicinal Chemistry
·
5
Ursolic acid-piperazine-dithiocarbamate ruthenium(II) polypyridyl complexes induced necroptosis in MGC-803 cells
2022
·
Hong Jiang
, Jian-Hua Wei
, et al.
·
Metallomics
·
5
Design, synthesis and biological evaluation of novel artesunate-selenylindole hybrids against colorectal cancer
2026
·
Jianlong Cao
, Ge Yuan
, et al.
·
Bioorganic Chemistry
Discovery of β-carboline derivatives as potent STAT3 dual phosphorylation inhibitor for hepatocellular carcinoma treatment
2026
·
Ziqing Jian
, Lanyi Wei
, et al.
·
European Journal of Medicinal Chemistry
Show more works
View as search
Works count:
6
Citation count:
27
H-index:
4
I10-index:
1
Year
Topic
Type